Rubinstein Lab OSUCCC – James

Por um escritor misterioso

Last updated 23 maio 2024

The Rubinstein Lab is focused on developing immune-based strategies for the treatment of cancer and human disease.

Claire VERSCHRAEGEN, Director of Medical Oncology, The Ohio State University, OH, OSU, The James Comprehensive Cancer Center

MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer

Rubinstein Lab OSUCCC – James

PDF) mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Cancer Patients

Claire VERSCHRAEGEN, Director of Medical Oncology, The Ohio State University, OH, OSU, The James Comprehensive Cancer Center

Mount Vernon News

Pelotonia Institute for Immuno-Oncology (@OhioStatePIIO) / X

Email - The Pelotonia Institute for Immuno-Oncology Winter 2020 Newsletter - Ohio State University Medical Center

Dr. Raphael Pollock, MD – Columbus, OH

Shared Resources OSUCCC – James

Transforming growth factor–β1 in regulatory T cell biology

BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. - Abstract - Europe PMC

Shared Resources OSUCCC – James

Recomendado para você